
Kerry Segal
Senior Biopharm Business Development (Licensing, Alliance Management and M&A) & Market Analytics & Market Research Professional 33 years of broad... | San Francisco Bay Area, San Francisco Bay Area, United States
*50 free lookup(s) per month.
No credit card required.
Kerry Segal’s Emails ks****@im****.com
Kerry Segal’s Phone Numbers No phone number available.
Social Media
Kerry Segal’s Location San Francisco Bay Area, San Francisco Bay Area, United States
Kerry Segal’s Expertise Senior Biopharm Business Development (Licensing, Alliance Management and M&A) & Market Analytics & Market Research Professional 33 years of broad and diverse biopharm industry experience including the past 24 years leading a wide variety of Bus Dev, M&A, Alliance Management & Market Insights/Analytics and Bus. Intelligence projects on a global basis. Areas of expertise include: (1) in-licensing, (2) out-licensing, (3) co-development & co-promotion deals, (4) asset acquisitions (APAs), (5) asset divestments, (6) mergers/acquisitions (M&A), (7) alliance mgmt, (8) corporate and brand strategy, (9) market intelligence and analytics, (10) commercial evaluations and financial modeling, and (11) secondary and primary market research to support said commercial evaluations, All of the aforementioned encompass a very broad array of therapeutic categories. In primary market research, my skills incorporate meticulous focus group and one-on-one (i.e. IDI) moderating. Skill-sets that are leveraged in projects include: (i) diplomatic negotiating, (ii) meticulous business instincts and judgement, (iii) creative problem solving, (iv) financial modeling (v) listening, (vii) organization, (viii) leadership Key traits crucial to personal success include: highly analytical, diplomatically persistent, detail oriented, collaborative, articulate, extremely passionate and results-oriented. Have closed, as lead negotiator, monumental value-generating "buy-side" and "sell-side" transactions totaling > 3.0B in deal value. Have executed the market research, commercial evaluations and financial models to support these transactions. Moderated > 250 focus groups, completed > 1,500 one-on-one interviews, led > 50 quant. market research studies and directed > 30 portfolio, pipeline and life-cycle management prioritization, optimization and rationalization projects incorporating extensive analytics. Feel free to request copy of CV.
Kerry Segal’s Current Industry Terns Pharmaceuticals
Kerry
Segal’s Prior Industry
Valeant Pharmaceuticals
|
Trovagene
|
Impax Pharmaceuticals
|
Paramount Advisors
|
Terns Pharmaceuticals
Not the Kerry Segal you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Terns Pharmaceuticals
Head Of Business Development
Mon Jan 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Paramount Advisors
Founder and Managing Director
Wed Jan 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Impax Pharmaceuticals
Vice President, Business Development
Sat Jan 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jan 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Trovagene
Chief Business Officer
Thu Jan 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Jan 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Valeant Pharmaceuticals
Senior Director, Global Bus. Dev. and Analytics
Sun Jan 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)